FDA inspects Fong Kee Tofu Company, Inc. in San Francisco on May 15, 2024

Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA
Dr. Christine S. Lee Acting Associate Commissioner for Minority Health and Director of the Office of Minority Health and Health Equity (OMHHE) in the Office of the Commissioner at the U.S. FDA - Official Website
0Comments

The Food and Drug Administration (FDA) issued nine citations to Fong Kee Tofu Company, Inc. in San Francisco following an inspection on May 15, 2024. The review covered food composition, standards, labeling, and economic concerns, according to data posted on the FDA’s website.

The FDA website indicates that the citations were delivered to the company as follows:

  • ‘You did not clean and sanitize your utensils or equipment in a manner that protects against contamination.’
  • ‘You did not exclude pests from your food plant to protect against contamination of food.’
  • ‘You did not clean your non-food contact surface in a manner and as frequently as necessary to protect against contamination.’
  • ‘Your equipment and utensils were not designed and constructed to be adequately cleaned or maintained to protect against contamination.’
  • ‘You did not inspect, segregate or otherwise handle raw materials and other ingredients to ensure they were clean and suitable for processing.’
  • ‘You did not conduct operations under conditions and controls necessary to minimize the potential for contamination of food.’
  • ‘You did not take an adequate measure to protect against inclusion of metal or extraneous material in food.’
  • ‘Your hazard analysis did not identify a hazard that required a preventive control.’
  • ‘Your written process preventive control procedures were not appropriate to significantly minimize or prevent the hazard requiring a preventive control.’

The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.

According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety and quality.

Information in this article was obtained from the U.S. Food and Drug Administration. The source data can be found here.



Related

Dr. Mehmet Oz CMS Administrator

San Mateo Medicaid Evaluation and Management payments amount to $13.8 million in 2024

San Mateo’s Medicaid payments for Evaluation and Management services climbed by 19.5% in 2024, signaling shifts in service use and payment practices.

Dr. Mehmet Oz CMS Administrator

Surgery services in San Francisco see $6,619,911 in Medicaid payments for 2024

In 2024, Medicaid providers in San Francisco submitted $6,619,911 in claims categorized as Surgery services, representing a 150.5% rise from the prior year.

Anthony DiGiorgio, Assistant Professor of Neurological Surgery, UCSF

UCSF Assistant Professor DiGiorgio on 340B: ‘340B has helped crush independent oncology practice’

UCSF Assistant Professor Anthony DiGiorgio said on May 13 that the federal 340B program disadvantages independent oncology practices by giving large hospital systems access to steeply discounted drugs.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from San Francisco Sun.